CYSTARAN (Sigma-Tau Pharmaceuticals, Inc.)
Welcome to the PulseAid listing for the CYSTARAN drug offered from Sigma-Tau Pharmaceuticals, Inc.. This Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: | Sigma-Tau Pharmaceuticals, Inc. |
NON-PROPRIETARY NAME: | cysteamine hydrochloride |
SUBSTANCE NAME: | CYSTEAMINE HYDROCHLORIDE |
TYPE: | HUMAN PRESCRIPTION DRUG |
PHARMA CLASS: | Cystine Depleting Agent [EPC],Cystine Disulfide Reduction [MoA] |
ROUTE: | OPHTHALMIC |
DOSAGE FORM: | SOLUTION |
MARKETING CATEGORY NAME: | NDA |
START MARKETING DATE: | 2012-12-30 |
END MARKETING DATE: | 0000-00-00 |
CYSTARAN HUMAN PRESCRIPTION DRUG Details:
Item Description | CYSTARAN from Sigma-Tau Pharmaceuticals, Inc. |
LABELER NAME: | Sigma-Tau Pharmaceuticals, Inc. |
DEA SCHEDULE: |
|
ACTIVE STRENGTH: | 6.5(mg/mL) |
START MARKETING DATE: | 2012-12-30 |
END MARKETING DATE: | 0000-00-00 |
PRODUCT ID: | 54482-020_ed04dacc-1245-403f-9041-2f52027e8ef4 |
PRODUCT NDC: | 54482-020 |
APPLICATION NUMBER: | NDA200740 |
Other CYSTEAMINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers: